← Back to headlines
Organon and Henlius Launch Prolia and Xgeva Biosimilars in Canada
Organon and Henlius have launched biosimilar versions of Prolia and Xgeva in Canada, expanding treatment options for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Shein Shares Plunge in Disappointing Hong Kong Stock Market Debut
29m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
40m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
43m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
49m ago